Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference

January 2, 2024

https://www.globenewswire.com/news-release/2024/01/02/2802631/0/en/Prime-Medicine-to-Present-at-42nd-Annual-J-P-Morgan-Healthcare-Conference.html

CAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine, will present a corporate overview at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 2:15 p.m. PT (5:15 p.m. ET) in San Francisco, CA.

Read more at globenewswire.com

Related news for (PRME)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.